← FDA Drug Approvals (Drugs@FDA)
SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PARKE DAVIS
Drug application
- FDA Application #
ANDA087948- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE
- Generic name
- Hydrochlorothiazide
- Active ingredients
- HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- PARKE DAVIS
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown